Schedule 13G ownership disclosure

Ovid therapeutics, Inc.

Security class unavailable · CUSIP: 690469101

Event date: 2021-03-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,082,200
Percent of class
9.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-21-000231
Form type
SC 13G/A
Filer
EcoR1 Capital Fund, L.P.
CIK
CIK 1567938
Filed
Mar 09, 2021
Reporting period
Mar 04, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub